Vertex Pharmaceuticals Director Bruce I. Sachs Disposes of 6,000 Shares via Gift
VERTEX PHARMACEUTICALS INC / MA
Subscribe to track VRTX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š¢ Form 4 Filing: Vertex Pharmaceuticals Inc ($VRTX) š¤ Insider: SACHS BRUCE I (Director) š Transaction: Gift (Code G) š Shares Disposed: 6,000 shares @ $0.00 š¼ Shares Remaining: 39,000 š Date: 2026-08-27 š Significance: Low (Non-market gift transaction)
Comprehensive Analysis
Executive Summary
On August 31, 2026, Vertex Pharmaceuticals Inc ($VRTX) filed a Form 4 detailing a transaction by Director Bruce I. Sachs.
Transaction Details
- Insider: Bruce I. Sachs (Director)
- Security: Common Stock
- Transaction Date: August 27, 2026
- Transaction Code:
G(Bona fide gift) - Shares Transacted: 6,000 shares disposed
- Price Per Share: $0.00
- Total Transaction Value: $0.00
- Post-Transaction Holdings: 39,000 direct shares
Analysis & Market Impact
- Trading Significance: Low. The disposition represents a charitable or personal gift (Code G) rather than an open-market sale or purchase. It does not reflect insider sentiment regarding company valuation or upcoming operational developments.
- Ownership Position: Following the transfer of 6,000 shares, Director Sachs retains 39,000 directly held shares of Vertex Pharmaceuticals common stock.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.
The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.
Always do your own due diligence and consult a licensed professional.